nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AAPS–FIP Summary Workshop Report: Pharmacogenetics in Individualized Medicine: Methods, Regulatory, and Clinical Applications
|
Moridani, Majid |
|
2009 |
11 |
2 |
p. 214-216 |
artikel |
2 |
A Multi-Tiered Analytical Approach For the Analysis and Quantitation of High-Molecular-Weight Aggregates in a Recombinant Therapeutic Glycoprotein
|
Hughes, Heather |
|
2009 |
11 |
2 |
p. 335-341 |
artikel |
3 |
An Investigation into the Importance of “Very Rapid Dissolution” Criteria for Drug Bioequivalence Demonstration using Gastrointestinal Simulation Technology
|
Kovačevi, Ivan |
|
2009 |
11 |
2 |
p. 381-384 |
artikel |
4 |
A Review of Imaging Agent Development
|
Agdeppa, Eric D. |
|
2009 |
11 |
2 |
p. 286-299 |
artikel |
5 |
Effects of Drug Transporters on Volume of Distribution
|
Grover, Anita |
|
2009 |
11 |
2 |
p. 250-261 |
artikel |
6 |
“Fit-for-Purpose” Method Validation and Application of a Biomarker (C-terminal Telopeptides of Type 1 Collagen) in Denosumab Clinical Studies
|
Wang, Jin |
|
2009 |
11 |
2 |
p. 385-394 |
artikel |
7 |
Handling Data Below the Limit of Quantification in Mixed Effect Models
|
Bergstrand, Martin |
|
2009 |
11 |
2 |
p. 371-380 |
artikel |
8 |
Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice
|
Schlosburg, Joel E. |
|
2009 |
11 |
2 |
p. 342-352 |
artikel |
9 |
Measuring Endocannabinoid Hydrolysis: Refining our Tools and Understanding
|
Marrs, William |
|
2009 |
11 |
2 |
p. 307-311 |
artikel |
10 |
Mechanistic Approaches to Predicting Oral Drug Absorption
|
Huang, Weili |
|
2009 |
11 |
2 |
p. 217-224 |
artikel |
11 |
Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development
|
Aldrich, Jane V. |
|
2009 |
11 |
2 |
p. 312-322 |
artikel |
12 |
Population-Based Mechanistic Prediction of Oral Drug Absorption
|
Jamei, Masoud |
|
2009 |
11 |
2 |
p. 225-237 |
artikel |
13 |
Predicting Drug–Drug Interactions: An FDA Perspective
|
Zhang, Lei |
|
2009 |
11 |
2 |
p. 300-306 |
artikel |
14 |
Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development
|
Chiba, Masato |
|
2009 |
11 |
2 |
p. 262-276 |
artikel |
15 |
Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data
|
Lukacova, Viera |
|
2009 |
11 |
2 |
p. 323-334 |
artikel |
16 |
Role of Physiological Intestinal Water in Oral Absorption
|
Sutton, Steven C. |
|
2009 |
11 |
2 |
p. 277-285 |
artikel |
17 |
Simulations of the Nonlinear Dose Dependence for Substrates of Influx and Efflux Transporters in the Human Intestine
|
Bolger, Michael B. |
|
2009 |
11 |
2 |
p. 353-363 |
artikel |
18 |
Structure-Based Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes
|
Li, Haiyan |
|
2009 |
11 |
2 |
p. 364-370 |
artikel |
19 |
The H2 Receptor Antagonist Nizatidine is a P-Glycoprotein Substrate: Characterization of its Intestinal Epithelial Cell Efflux Transport
|
Dahan, Arik |
|
2009 |
11 |
2 |
p. 205-213 |
artikel |
20 |
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for Treatment of orf virus Infections
|
Sonvico, Fabio |
|
2009 |
11 |
2 |
p. 242-249 |
artikel |
21 |
Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations
|
Fast, Douglas M. |
|
2009 |
11 |
2 |
p. 238-241 |
artikel |